CASE REPORT
Accepted on 23 Jun 2025
Cadonilimab plus anlotinib with radiotherapy for lung adenocarcinoma with pancreatic metastasis in posterior line therapy: A case report
doi 10.3389/fimmu.2025.1610710
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Overcoming Resistance to Immune Checkpoint Inhibitors: Mechanisms and Strategies in Cancer Therapy
Overcoming Resistance to Immune Checkpoint Inhibitors: Mechanisms and Strategies in Cancer Therapy
655
Total downloads
3,703
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
MINI REVIEW
Published on 21 May 2025
Role of TGFβ-activated cancer-associated fibroblasts in the resistance to checkpoint blockade immunotherapy
doi 10.3389/fonc.2025.1602452
- 677 views
REVIEW
Published on 21 Mar 2025
The role of B2M in cancer immunotherapy resistance: function, resistance mechanism, and reversal strategies
doi 10.3389/fimmu.2025.1512509
- 1,818 views
- 3 citations
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: